BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
University Hospitals Plymouth NHS Trust (UHP) is exploring options for the development of a new Pharmacy Aseptic Services suite. The proposed facility is intended to provide a comprehensive range of aseptic services including:
Chemotherapy preparation
Centralised Intravenous Additive Services (CIVAS)
Outpatient Antimicrobial Therapy (OPAT/OPIT) support
Clinical Trials aseptic support
Future-proofed capacity for expected demand growth
As part of this appraisal, the Trust is considering a range of potential delivery and funding models, including the possibility of forming a Joint Venture or other partnership with the private sector.
The purpose of this soft market testing exercise is to understand:
The level of interest from suppliers and investors in partnering with the Trust
The range of commercial, technical, and operational models available in the market
Key risks, dependencies, and proposed approaches
Potential timelines and delivery routes
Options that best support service continuity during construction
This exercise is not a call for competition, nor part of a formal procurement process. Responses received will help shape the Trust’s strategy and any potential future procurement.
Preliminary market engagement notice (UK2). The buyer wants to talk to suppliers before designing the procurement. Taking part is how to shape it.
Bids are submitted through the buyer’s own portal, not on this site. Read the full notice on Find a Tender before relying on any date here.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Jul 2027 – Jun 2037 | - | planning |